infiltrating bladder urothelial carcinoma sarcomatoid variant

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, hydronephrosis, infiltrating bladder urothelial carcinoma sarcomatoid variant, kidney disorder, kidney pelvis sarcomatoid transitional cell carcinoma, micropapillary variant infiltrating bladder urothelial carcinoma, neoplasm, plasmacytoid variant infiltrating bladder urothelial carcinoma, renal pelvis urothelial carcinoma, ureter cancer, ureter transitional cell carcinoma, ureteral disorder, urethra neoplasm, urethra transitional cell carcinoma, urethral disorder, urinary system disorder	Active, not recruiting	Early phase 1	2026-09-14		NCT02812420
Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, infiltrating bladder urothelial carcinoma sarcomatoid variant, micropapillary variant infiltrating bladder urothelial carcinoma, neoplasm, plasmacytoid variant infiltrating bladder urothelial carcinoma, transitional cell carcinoma	Active, not recruiting	Phase 2	2026-07-16		NCT03744793

Clinical trials